(Reuters) -Johnson & Johnson ( JNJ ) will withdraw a device to treat acid reflux disease from markets outside the U.S., Bloomberg News reported on Tuesday, citing a company letter sent to doctors.

The company has decided to withdraw the product, called LINX Reflux Management System, from March for commercial reasons, and not due to safety or efficacy issues, the report said.

J&J did not immediately respond to a Reuters request for comment.

The device was approved for patients with chronic gastroesophageal reflux disease, a condition in which the stomach contents leak backward from the stomach into the food pipe.

It is a flexible ring of small magnets placed around a band of muscles located at the base of the esophagus to help keep them closed to prevent reflux, according to the company.